Hsbc Global Res Downgrades Haleon (NYSE:HLN) to Hold

Haleon (NYSE:HLN) was downgraded by equities researchers at Hsbc Global Res from a “strong-buy” rating to a “hold” rating in a note issued to investors on Wednesday,Zacks.com reports.

Several other brokerages have also recently issued reports on HLN. HSBC restated a “hold” rating on shares of Haleon in a research note on Wednesday. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Finally, Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Five research analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $10.95.

Haleon Trading Down 1.5 %

Shares of NYSE:HLN opened at $10.39 on Wednesday. Haleon has a 52-week low of $7.89 and a 52-week high of $10.80. The stock has a market cap of $47.02 billion, a price-to-earnings ratio of 30.55, a PEG ratio of 2.82 and a beta of 0.25. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The business has a 50-day moving average price of $9.65 and a 200-day moving average price of $9.85.

Haleon (NYSE:HLN) last announced its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The firm had revenue of $3.54 billion during the quarter, compared to analysts’ expectations of $3.38 billion. Equities analysts predict that Haleon will post 0.43 EPS for the current year.

Institutional Trading of Haleon

Several institutional investors have recently bought and sold shares of the business. Brucke Financial Inc. acquired a new stake in Haleon in the fourth quarter valued at approximately $96,000. Forum Financial Management LP grew its holdings in Haleon by 52.2% in the fourth quarter. Forum Financial Management LP now owns 30,705 shares of the company’s stock valued at $293,000 after purchasing an additional 10,530 shares during the period. Vise Technologies Inc. grew its holdings in Haleon by 21.5% in the fourth quarter. Vise Technologies Inc. now owns 59,125 shares of the company’s stock valued at $564,000 after purchasing an additional 10,468 shares during the period. Principal Street Partners LLC acquired a new stake in Haleon in the fourth quarter valued at approximately $472,000. Finally, Wolverine Trading LLC acquired a new stake in Haleon in the fourth quarter valued at approximately $208,000. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.